Skip to main content
Genes & Diseases logoLink to Genes & Diseases
. 2024 Jan 20;11(4):101211. doi: 10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401]

Uttpal Anand a, Abhijit Dey b,1, Arvind K Singh Chandel c,1, Rupa Sanyal d, Amarnath Mishra e,, Devendra Kumar Pandey f, Valentina De Falco g, Arun Upadhyay h, Ramesh Kandimalla i,j, Anupama Chaudhary k, Jaspreet Kaur Dhanjal l, Saikat Dewanjee m, Jayalakshmi Vallamkondu n, José M Pérez de la Lastra o,∗∗
PMCID: PMC10990713  PMID: 38572324

In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”.

The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

Footnotes

Peer review under responsibility of Chongqing Medical University.

Contributor Information

Amarnath Mishra, Email: amishra5@amity.edu, prof.amarnathmishra@gmail.com.

José M. Pérez de la Lastra, Email: jm.perezdelalastra@csic.es.


Articles from Genes & Diseases are provided here courtesy of Chongqing Medical University

RESOURCES